OKUR

OnKure Therapeutics, Inc. Class A · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN US68277Q1058

Performance

-22.62%

-48.87%

-44.5%

-46.96%

-47.63%

YTD

-37.46%

Profile

Advanced Technical Analysis

Technical Analysis of OKUR 2024-12-20

The Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 56 suggests a neutral stance, and the overall Technical Score of 33 reinforces the bearish outlook. Collectively, these scores imply a predominantly negative sentiment in the stock, with limited bullish momentum.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of OKUR

Stock Rank

Recent News & Updates

2024-12-09 18:00
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219(Globenewswire)
2024-11-25 04:31
OnKure Announces New Date for Upcoming Investor Call(Globenewswire)
2024-11-05 03:05
OnKure to Present at the Stifel 2024 Healthcare Conference(Globenewswire)
2024-11-01 05:30
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium(Globenewswire)
2024-10-06 16:32
OnKure and Reneo Pharmaceuticals complete merger(Yahoo Finance)
2024-10-04 04:57
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million(Globenewswire)
2024-10-02 08:20
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure(Globenewswire)
2024-08-12 19:35
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-05-15 22:01
Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing(Yahoo Finance)
2024-05-12 20:25
Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise(Yahoo Finance)
2024-05-12 19:35
Reneo Pharmaceuticals and OnKure Announce Proposed Merger(Globenewswire)
2024-05-07 01:53
RPHM Stock Earnings: Reneo Pharmaceuticals Beats EPS for Q1 2024(Investorplace)
2024-05-06 19:35
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results(Globenewswire)
2024-03-28 00:53
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023(Investorplace)
2024-03-27 19:35
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update(Globenewswire)
2024-03-24 19:00
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors(Globenewswire)
2023-12-21 03:13
These Stocks under $10 Are Poised To Explode(Yahoo Finance)
2023-12-14 21:19
Reneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Study(Yahoo Finance)
2023-12-13 23:35
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?(Yahoo Finance)
2023-12-13 20:05
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)(Globenewswire)
2023-11-13 04:04
Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results(Yahoo Finance)
2023-11-12 18:35
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-11-01 19:50
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences(Globenewswire)
2023-10-24 19:50
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings(Globenewswire)
2023-10-20 01:22
12 Best Performing Biotech Stocks in 2023(Yahoo Finance)
2023-10-08 19:50
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)(Globenewswire)
2023-10-05 20:30
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit(Globenewswire)
2023-08-28 19:35
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences(Yahoo Finance)
2023-08-09 19:35
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-09 19:31
Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) stock price dropped 10% last week; private equity firms would not be happy(Yahoo Finance)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.